NCT05184569View on ClinicalTrials.gov

Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology

PHASE1RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 14, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Semantic Dementia
Interventions
DRUG

Verdiperstat

Oral, extended release (ER) tablet

Trial Locations (5)

19104

RECRUITING

University of Pennsylvania, Philadelphia

55905

RECRUITING

Mayo Clinic, Rochester

60611

RECRUITING

Northwestern University, Chicago

77030

RECRUITING

Houston Methodist Hospital - Nantz National Alzheimer Center, Houston

94158

RECRUITING

UCSF Memory and Aging Center, San Francisco

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Alzheimer's Association

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Peter Ljubenkov, MD

OTHER